Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APATINIB vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APATINIB vs APREPITANT: Safety Overview

Metric APATINIB APREPITANT
Total FAERS Reports 155 5,620
Deaths Reported 25 1,195
Death Rate 16.1% 21.3%
Hospitalizations 42 2,917
Average Patient Age 54.1 yrs 52.8 yrs
% Female Patients 52.9% 70.9%
FDA Approval Date N/A Dec 17, 2015
Manufacturer N/A Heron Therapeutics, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription